Cubresa’s SPECT scanner was used to determine if a novel molecular label, TRV6001, in development for in vivo imaging of the BChE enzyme present in the brains of Alzheimer’s Disease patients follows the known distribution of the enzyme in animal models of the disease.
from Dementia Big http://ift.tt/2fWO12V via alcoholic dementia
http://ift.tt/2gCPStB
No comments:
Post a Comment